Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
- Label Image - lbl500905495
- Levetiracitam Tablets, USP-figure07 - levetiracetam tablets usp 1
- 9596f2fe-figure-01 - levetiracetam tablets usp 2
- 20 - levetiracetam tablets usp 3
- 14 - levetiracetam tablets usp 4
- 0 - levetiracetam tablets usp 5
- 54 - levetiracetam tablets usp 6
- 78 - levetiracetam tablets usp 7
- 10 - levetiracetam tablets usp 8
Product Label Images
The following 9 images provide visual information about the product associated with Levetiracetam NDC 50090-5495 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500905495
This is a medication with the name Levitiracetam with a dosage of 1600 mg. The medication comes in a pack of 30 tablets and should be stored at a temperature of 68-107 degrees.*
Levetiracitam Tablets, USP-figure07 - levetiracetam tablets usp 1
This appears to be a formula for estimating the estimated glomerular filtration rate (eGFR) of female patients based on their age, weight, and serum creatinine level. The formula involves calculating CLer, which is then adjusted for body surface area. The given text seems to be incomplete as important context and units are missing.*
20 - levetiracetam tablets usp 3
This text represents a clinical trial comparing the effectiveness of the medication Levetiracetam with a placebo in treating a certain condition. The trial includes 95 participants in the placebo group and 97 and 101 participants in two different dosages of Levetiracetam groups.*
0 - levetiracetam tablets usp 5
This appears to be a set data results or statistics, with some percentages and medical terms, including two groups (a Placebo group and a Levetiracetam group) mentioned with their corresponding sample sizes. However, without additional context or explanation, it is difficult to provide a specific description or interpretation of this data.*
54 - levetiracetam tablets usp 6
The given text displays some percentages and patient counts for placebo and a medication called "Levetiracetam." However, no context or further information is available, so it's not possible to give a meaningful description with the given text.*
78 - levetiracetam tablets usp 7
The text provides the percentage of patients in two groups - 43.1% in an unspecified group and 19.6% in another. The data is then compared to a placebo group consisting of 51 people. The text indicates that the Levetiracetam group consisting of 58 people was statistically significant compared to the placebo group.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.